Oaktree Specialty Lending (OCSL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Feb, 2026Executive summary
Special meeting scheduled for March 3, 2026, to consider a key proposal.
Shareholders are urged to vote in advance to ensure quorum and avoid postponement.
Multiple voting methods are available: online, phone, QR code, and mail.
Voting matters and shareholder proposals
Proposal seeks authorization to issue common stock below net asset value (NAV), up to 25% of outstanding shares.
No immediate plans to issue shares below NAV, but approval provides future flexibility.
Not voting is equivalent to voting against the proposal.
Board of directors and corporate governance
Board of Directors recommends voting FOR the proposal.
CEO and President have signed the solicitation, emphasizing its importance.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Oaktree Specialty Lending
- Net investment income was stable as NAV fell to $16.30 and a $0.40 dividend was declared.OCSL
Q1 202613 Apr 2026 - $2.9B portfolio, 86% senior secured, strong liquidity, and stable income with robust new investments.OCSL
Investor presentation10 Mar 2026 - Directors and auditor ratified with no stockholder questions; all proposals approved.OCSL
AGM 20263 Mar 2026 - Adjusted NII per share $0.55, NAV $18.19, fee cut, and $0.55/share dividend declared.OCSL
Q3 20242 Feb 2026 - Election of two directors and auditor ratification are up for vote at the 2026 annual meeting.OCSL
Proxy Filing16 Jan 2026 - Shareholders will vote on director elections and auditor ratification, with strong governance oversight.OCSL
Proxy Filing16 Jan 2026 - Q4 NII steady at $0.55/share; NAV down to $18.09; strong liquidity; higher non-accruals.OCSL
Q4 202413 Jan 2026 - Oaktree's $100M equity at NAV boosts liquidity as income dips and new dividend policy starts.OCSL
Q1 20258 Jan 2026 - Stockholders are asked to approve potential issuance of shares below NAV, capped at 25%.OCSL
Proxy Filing8 Jan 2026